tiprankstipranks
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
US Market
Holding ITOS?
Track your performance easily

iTeos Therapeutics (ITOS) Technical Analysis

175 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
iTeos Therapeutics’s (ITOS) Moving Averages Convergence Divergence (MACD) indicator is -0.52, suggesting iTeos Therapeutics is a Buy.
iTeos Therapeutics’s (ITOS) 20-Day exponential moving average is 8.76, while iTeos Therapeutics’s (ITOS) share price is $8.13, making it a Sell.
iTeos Therapeutics’s (ITOS) 50-Day exponential moving average is 10.11, while iTeos Therapeutics’s (ITOS) share price is $8.13, making it a Sell.

iTeos Therapeutics (ITOS) Pivot Points

Nov 22, 2024, 01:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.49
7.57
7.74
7.82
7.99
8.07
8.24
Fibonacci
7.57
7.67
7.73
7.82
7.92
7.98
8.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

iTeos Therapeutics (ITOS) Moving Averages

Nov 22, 2024, 01:15 AM
Period
Simple
Exponential
MA5
8.06Sell
8.11Sell
MA10
8.62Sell
8.40Sell
MA20
8.72Sell
8.76Sell
MA50
9.79Sell
10.11Sell
MA100
12.97Sell
11.60Sell
MA200
13.06Sell
11.81Sell
iTeos Therapeutics’s (ITOS) 10-Day exponential moving average is 8.40, while iTeos Therapeutics’s (ITOS) share price is $8.13, making it a Sell.
iTeos Therapeutics’s (ITOS) 100-Day exponential moving average is 11.60, while iTeos Therapeutics’s (ITOS) share price is $8.13, making it a Sell.
iTeos Therapeutics’s (ITOS) stock price is $8.13 and iTeos Therapeutics’s (ITOS) 50-day simple moving average is 9.79, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $8.13 and iTeos Therapeutics’s (ITOS) 100-day simple moving average is 12.97, creating a Sell signal.
iTeos Therapeutics’s (ITOS) stock price is $8.13 and iTeos Therapeutics’s (ITOS) 200-day simple moving average is 13.06, creating a Sell signal.

iTeos Therapeutics (ITOS) Technical Indicators

Nov 22, 2024, 01:15 AM
Name
Value
Implied Action
RSI (14)
29.40
Buy
STOCH (9,6)
8.05
Buy
STOCHRSI (14)
8.05
Buy
MACD (12,26)
-0.52
Buy
ADX (14)
22.59
Neutral
Williams %R
-90.73
Buy
CCI (14)
-136.67
Buy
ATR (14)
0.53
-
Ultimate Oscillator
35.30
Neutral
ROC
-7.10
Sell
iTeos Therapeutics’s (ITOS) Relative Strength Index (RSI) is 29.40, creating a Buy signal.
iTeos Therapeutics’s (ITOS) Trend Strength Indicator (ADX) is 22.59, creating a Neutral signal.
iTeos Therapeutics’s (ITOS) Commodity Channel Index (CCI) is -136.67, creating a Buy signal.
iTeos Therapeutics’s (ITOS) Price Rate of Change (ROC) is -7.10, creating a Sell signal.

FAQ

Is ITOS a Buy, Hold, or Sell?
Based on ITOS’s technical indicators, ITOS is a Sell.
    What is ITOS’s RSI (14)?
    ITOS’s RSI (14) is 29.40, which suggests ITOS is a Buy.
      What is ITOS’s MACD?
      ITOS’s MACD is -0.52, which suggests ITOS is a Buy.
        What is ITOS’s 5-day moving average?
        ITOS’s 5-day moving average is 8.06, which suggests ITOS is a Sell.
          What is ITOS’s 20-day moving average?
          ITOS 20-day moving average is 8.72, which suggests ITOS is a Sell.
            What is ITOS’s 50-day moving average?
            ITOS’s 50-day moving average is 9.79, which suggests ITOS is a Sell.
              What is ITOS’s 200-day moving average?
              ITOS’s 200-day moving average is 13.06, which suggests ITOS is a Sell.
                What is ITOS’s Williams % R (14)?
                ITOS’s Williams % R (14) is -90.73, which suggests ITOS is a Buy.
                  What is ITOS’s CCI (14)?
                  ITOS’s CCI (14) is -136.67, which suggests ITOS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis